Optimizing resection for "responding" hepatic metastases after neoadjuvant chemotherapy

Abstract

Fifty percent of patients with colorectal cancer will develop metastases at some time during their disease, with the liver being the most common site. Recent advances in the treatment of metastatic colorectal cancer have led to a change in treatment paradigm. What follows is a review of the surgical management of hepatic colorectal metastases responding to neoadjuvant chemotherapy. In addition, the complexity of treating patients with "disappearing" colorectal liver metastases is discussed. © 2010 Wiley-Liss, Inc. Copyright © 2010 Wiley-Liss, Inc.